Virax Biolabs Group Ltd

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Virax Biolabs Group Ltd had 4.23M in cash and cash equivalents.

Virax Biolabs Group Ltd reported 964.75K in total liabilities as of the latest reported quarter, including 673.21K in current liabilities and 291.54K in non-current liabilities.

As of the latest reported quarter, Virax Biolabs Group Ltd's total assets were 8.32M, consisting of 6.83M in current assets and 1.50M in non-current assets.

Virax Biolabs Group Ltd reported 7.33M in total shareholders' equity as of the latest reported quarter.